Cencora solution

FormularyDecisions® for biopharma companies

Exchange information with thousands of healthcare decision-makers and connect with the largest active online healthcare decision-maker community in the U.S. to share information throughout your product's lifecycle.
Verfügbar für
  • Pharma
  • Gesundheitswesen

Discover more

Contact sales

Whether you have questions about our capabilities or need more information, our experts are here to assist you. 

Maximize brand visibility

FormularyDecisions is a secure, online platform facilitating the bidirectional exchange of information between biopharma companies and active healthcare decision-makers representing over 298 million pharmacy benefit manager covered lives in the US.

From pre-approval to post-launch, get unrivaled insight into what healthcare decision-makers think of your product and those of your competitors, and gain feedback to better inform your market access strategies.
Available in English only

Proaktives Teilen von eDossiers für nicht zugelassene Produkte und nicht zugelassene Anwendungen

In Übereinstimmung mit dem Pre-Approval Information Exchange (PIE) Act 2022 der FDA hat FormularyDecisions eine neue Funktion eingeführt, die es biopharmazeutischen Unternehmen ermöglicht, nicht zugelassene Produkte und nicht zugelassene Verwendungs-eDossiers proaktiv auszutauschen. Wenn diese Funktion aktiviert ist, müssen Entscheidungsträger im Gesundheitswesen keine Zugangsanträge mehr über unser eRequest-System stellen, was ihre Überprüfung der verfügbaren Informationen vor Entscheidungen über potenzielle Produkte und Indikationen vereinfacht.  

Wenn Sie diese neue Funktionalität erkunden möchten, können Sie sich gerne an uns wenden: 

Introducing "Product Perspectives"

Every biopharma company is unique, which is why the FormularyDecisions platform is customizable for small, medium, and large biopharma companies. From acting as an extension of your field team to effectively communicating the value of your diverse product portfolio, FormularyDecisions is equipped to help you streamline and optimize healthcare decision-maker engagement, giving you the competitive edge you need.

"Product Perspectives" is a new offering designed to equip biopharma subscribers with deeper insights into how healthcare decision-makers perceive their product and the broader market landscape.

Drive healthcare decision-maker activity vs your competitors

Boost your digital engagement strategy with a unified platform. Nearly all surveyed healthcare decision-makers highlight the need for biopharma companies to blend traditional and digital channels for effective communication. With healthcare decision-maker activity on FormularyDecisions increasing eightfold in the past five years, optimize your approach and connect more effectively today.

FormularyDecisions ist ein vertrauenswürdiger AMCP-Partner

AMCP ist der Berufsverband, der Patienten dabei hilft, die benötigten Medikamente zu einem erschwinglichen Preis zu erhalten.

Die vielfältigen Mitglieder der AMCP, bestehend aus Apothekern, Ärzten, Krankenschwestern, biopharmazeutischen Fachleuten und anderen Interessengruppen, nutzen ihr Fachwissen in den Bereichen klinische Evidenz und Wirtschaftlichkeit, um die Gestaltung des Nutzens von Medikamenten und das Gesundheitsmanagement der Bevölkerung zu optimieren und Patienten beim Zugang zu kostengünstigen und sicheren Medikamenten und anderen Arzneimitteltherapien zu helfen. AMCP-Mitglieder verbessern das Leben von fast 300 Millionen Amerikanern, die von privaten und öffentlichen Krankenversicherungen, Apothekenleistungsmanagementfirmen und neuen Versorgungsmodellen betreut werden.

Explore our webinar library

View our curated collection of informative webinars that cover a wide range of healthcare topics. Stay current with the latest sessions by registering for upcoming webinars and accessing past recordings.
 

Connect with our experts

Reach healthcare decision-makers like never before

FormularyDecisions is a secure online platform facilitating the bi-directional exchange of information between biopharma companies and active healthcare decision-makers. From pre-approval to post-launch, subscribing organizations get unrivaled insight into payers perception of their products and those of industry competitors, and gain feedback to better inform market access strategies.

Because every biopharma company is unique, the FormularyDecisions platform is highly customizable. Enterprise users often host multiple products at once, and strategic consulting assists subscribing companies in efficiently customizing their platform so they can drive more effective healthcare decision-makers engagement and maintain a competitive edge.